These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10605378)

  • 1. Cage dimeric N-acyl- and N-acyloxy-4-aryl-1,4-dihydropyridines as first representatives of a novel class of HIV-1 protease inhibitors.
    Hilgeroth A; Billich A
    Arch Pharm (Weinheim); 1999 Nov; 332(11):380-4. PubMed ID: 10605378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of the first N-alkyl cage dimeric 4-aryl-1,4-dihydropyridines as novel nonpeptidic HIV-1 protease inhibitors.
    Hilgeroth A; Wiese M; Billich A
    J Med Chem; 1999 Nov; 42(22):4729-32. PubMed ID: 10579836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of first bishydroxymethyl-substituted cage dimeric 4-aryl-1,4-dihydropyridines as HIV-1 protease inhibitors.
    Hilgeroth A; Lilie H
    Eur J Med Chem; 2003 May; 38(5):495-9. PubMed ID: 12767599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cage dimeric 4-aryl-1,4-dihydropyridines as promising lead structures for the development of a novel class of HIV-1 protease inhibitors.
    Hilgeroth A; Billich A
    Arch Pharm (Weinheim); 1999 Jan; 332(1):3-5. PubMed ID: 10073137
    [No Abstract]   [Full Text] [Related]  

  • 5. Dimeric 4-Aryl-1,4-dihydropyridines: development of a third class of nonpeptidic HIV-1 protease inhibitors.
    Hilgeroth A
    Mini Rev Med Chem; 2002 Jun; 2(3):235-45. PubMed ID: 12370065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological evaluation of first N-alkyl syn dimeric 4-aryl-1,4-dihydropyridines as competitive HIV-1 protease inhibitors.
    Hilgeroth A; Billich A; Lilie H
    Eur J Med Chem; 2001 Apr; 36(4):367-74. PubMed ID: 11461762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dimeric 4-aryl-1,4-dihydropyridines as novel HIV-1 protease inhibitors--affinities to intestinal P-glycoprotein.
    Hilgeroth A; Dressler C; Neuhoff S; Spahn-Langguth H; Langguth P
    Pharmazie; 2000 Oct; 55(10):784-5. PubMed ID: 11082847
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of azacyclic urea A-98881 as HIV-1 protease inhibitor with cage dimeric N-benzyl 4-(4-methoxyphenyl)-1,4-dihydropyridine as representative of a novel class of HIV-1 protease inhibitors: a molecular modeling study.
    Hilgeroth A; Fleischer R; Wiese M; Heinemann FW
    J Comput Aided Mol Des; 1999 May; 13(3):233-42. PubMed ID: 10216831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological evaluation of bishydroxymethyl-substituted cage dimeric 1,4-dihydropyridines as a novel class of p-glycoprotein modulating agents in cancer cells.
    Richter M; Molnár J; Hilgeroth A
    J Med Chem; 2006 May; 49(9):2838-40. PubMed ID: 16640345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First bioanalytical evaluation of nonpeptidic cage dimeric HIV-1 protease inhibitor N-benzyl 4-aryl-1,4-dihydropyridine H17: biotransformation and toxicity on Hep G2 cells.
    Hilgeroth A; Langner A
    Arch Pharm (Weinheim); 2000 Jan; 333(1):32-4. PubMed ID: 10675987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of some novel N-aryl-1,4-dihydropyridines as potential antitubercular agents.
    Trivedi AR; Dodiya DK; Dholariya BH; Kataria VB; Bhuva VR; Shah VH
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5181-3. PubMed ID: 21824772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel HIV-1 protease inhibitors using tertiary amine as P2-ligands.
    Yang ZH; Bai XG; Zhou L; Wang JX; Liu HT; Wang YC
    Bioorg Med Chem Lett; 2015 May; 25(9):1880-3. PubMed ID: 25838144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and QSAR studies on N-aryl heteroarylisopropanolamines, a new class of non-peptidic HIV-1 protease inhibitors.
    Di Santo R; Costi R; Artico M; Massa S; Ragno R; Marshall GR; La Colla P
    Bioorg Med Chem; 2002 Aug; 10(8):2511-26. PubMed ID: 12057640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereocontrolled synthesis and biological activity of two diastereoisomers of the potent HIV-1 protease inhibitor saquinavir.
    Righi G; Ciambrone S; Bonini C; Campaner P
    Bioorg Med Chem; 2008 Jan; 16(2):902-8. PubMed ID: 17964171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design and synthesis of a novel series of HIV-1 protease inhibitors.
    Takashiro E; Nakamura Y; Miyamoto S; Ozawa Y; Sugiyama A; Fujimoto K
    Bioorg Med Chem; 1999 Sep; 7(9):2105-14. PubMed ID: 10530961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prodrugs of HIV protease inhibitors-saquinavir, indinavir and nelfinavir-derived from diglycerides or amino acids: synthesis, stability and anti-HIV activity.
    Gaucher B; Rouquayrol M; Roche D; Greiner J; Aubertin AM; Vierling P
    Org Biomol Chem; 2004 Feb; 2(3):345-57. PubMed ID: 14747863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,2,5,6-tetra-O-benzyl-D-mannitol derivatives as novel HIV protease inhibitors.
    Bouzide A; Sauvé G; Sévigny G; Yelle J
    Bioorg Med Chem Lett; 2003 Oct; 13(20):3601-5. PubMed ID: 14505679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of new simple indolic non peptidic HIV Protease inhibitors: the effect of different substitution patterns.
    Bonini C; Chiummiento L; Di Blasio N; Funicello M; Lupattelli P; Tramutola F; Berti F; Ostric A; Miertus S; Frecer V; Kong DX
    Bioorg Med Chem; 2014 Sep; 22(17):4792-802. PubMed ID: 25074848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, antibacterial and antimycobacterial activities of some new 4-aryl/heteroaryl-2,6-dimethyl-3,5-bis-N-(aryl)-carbamoyl-1,4-dihydropyridines.
    Sirisha K; Bikshapathi D; Achaiah G; Reddy VM
    Eur J Med Chem; 2011 May; 46(5):1564-71. PubMed ID: 21382653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of novel inhibitors of the HIV-1 protease: difunctional enols of simple N-protected amino acids.
    Vaillancourt M; Vanasse B; Le Berre N; Cohen E; Sauvé G
    Bioorg Med Chem; 1994 May; 2(5):343-55. PubMed ID: 7922146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.